Related references
Note: Only part of the references are listed.Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic A Randomized Clinical Trial
Jose Alexandre S. Crippa et al.
JAMA NETWORK OPEN (2021)
Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders A Systematic Review and Meta-analysis
Eva A. M. van Dis et al.
JAMA PSYCHIATRY (2020)
Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers
Dvora Izgelov et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial
Febe E. van der Flier et al.
BMC PSYCHIATRY (2019)
The Divergent Effects of CDPPB and Cannabidiol on Fear Extinction and Anxiety in a Predator Scent Stress Model of PTSD in Rats
John Shallcross et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2019)
Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
Ila M. Linares et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2019)
Integrating data from the Investigational Medicinal Product Dossier/investigator's brochure. A new tool for translational integration of preclinical effects
Joop van Gerven et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
Antonio W. Zuardi et al.
Frontiers in Pharmacology (2017)
Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction
Chenchen Song et al.
FRONTIERS IN PHARMACOLOGY (2016)
Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders
Regimantas Jurkus et al.
FRONTIERS IN PHARMACOLOGY (2016)
UPDATED META-ANALYSIS OF CLASSICAL FEAR CONDITIONING IN THE ANXIETY DISORDERS
Puck Duits et al.
DEPRESSION AND ANXIETY (2015)
Maximizing exposure therapy: An inhibitory learning approach
Michelle G. Craske et al.
BEHAVIOUR RESEARCH AND THERAPY (2014)
Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors
Fabricio H. Do Monte et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
D-Cycloserine Enhancement of Fear Extinction is Specific to Successful Exposure Sessions: Evidence from the Treatment of Height Phobia
Jasper A. J. Smits et al.
BIOLOGICAL PSYCHIATRY (2013)
Recurrence of anxiety disorders and its predictors
Willemijn D. Scholten et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Amir Englund et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity
O. Gunduz-Cinar et al.
MOLECULAR PSYCHIATRY (2013)
Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
Valeria Almeida et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Cannabidiol enhances consolidation of explicit fear extinction in humans
Ravi K. Das et al.
PSYCHOPHARMACOLOGY (2013)
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors
Alline Cristina Campos et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2012)
Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1
I. Heitland et al.
TRANSLATIONAL PSYCHIATRY (2012)
Non-adherence and non-response in the treatment of anxiety disorders
Steven Taylor et al.
JOURNAL OF ANXIETY DISORDERS (2012)
The size and burden of mental disorders and other disorders of the brain in Europe 2010
H. U. Wittchen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
Jose Alexandre S. Crippa et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naive Social Phobia Patients
Mateus M. Bergamaschi et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent
Mateus Machado Bergamaschi et al.
CURRENT DRUG SAFETY (2011)
Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats
Jose Inacio Lemos et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Sagnik Bhattacharyya et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Biomarkers of Endocannabinoid System Activation in Severe Obesity
Jack C. Sipe et al.
PLOS ONE (2010)
Distinct Effects of Delta 9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
Paolo Fusar-Poli et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Endocannabinoid-Mediated Control of Synaptic Transmission
Masanobu Kano et al.
PHYSIOLOGICAL REVIEWS (2009)
Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats
Rafael M. Bitencourt et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test
Fabricio A. Moreira et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats
Leonardo B. M. Resstel et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use
KP Chiang et al.
HUMAN MOLECULAR GENETICS (2004)
Effect of low doses of Δ9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats
LA Parker et al.
PSYCHOPHARMACOLOGY (2004)
The endogenous cannabinoid system controls extinction of aversive memories
G Marsicano et al.
NATURE (2002)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Localization of the CB1 cannabinoid receptor in the rat brain.: An immunohistochemical study
G Moldrich et al.
PEPTIDES (2000)